These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17060485)

  • 41. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.
    Corral DA; Sella A; Pettaway CA; Amato RJ; Jones DM; Ellerhorst J
    J Urol; 1998 Nov; 160(5):1770-4. PubMed ID: 9783949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas.
    Iop A; Cartei G; Vigevani E; Clocchiatti L; Mansutti M; Sibau AM
    Am J Clin Oncol; 1997 Oct; 20(5):515-8. PubMed ID: 9345340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
    Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
    Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin.
    Giannone L; Brenner DE; Jones HW; Greco FA; Burnett LS
    Gynecol Oncol; 1987 Feb; 26(2):178-82. PubMed ID: 2433196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix.
    Gebbia V; Caruso M; Testa A; Mauceri G; Borsellino N; Chiarenza M; Pizzardi N; Palmeri S
    Oncology; 2002; 63(1):31-7. PubMed ID: 12187068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role of neoadjuvant chemotherapy in the treatment of advanced head and neck tumors. Results of two randomized therapeutical trials conducted at the Institut Curie on 208 patients].
    Brunin F; Rodriguez J; Jaulerry C; Mosseri V; Jouve M; Point D; Asselain B; Validire P; Blaszka B; Zafrani B
    Bull Cancer; 1992; 79(9):893-904. PubMed ID: 1283088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
    Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
    J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
    Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined chemotherapy using cisplatin, ifosfamide and bleomycin (PIB) in the treatment of advanced and recurrent cervical carcinoma.
    Tay SK; Lai FM; Soh LT; Ho TH; Ang PT; Au E
    Aust N Z J Obstet Gynaecol; 1992 Aug; 32(3):263-6. PubMed ID: 1280100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A case of recurrent squamous cell carcinoma of cervix successfully treated with BOMP].
    Matsui R; Kashihara K; Higashi T; Seo K; Taoka Y; Yoshida S; Nishitani H; Takegawa Y; Hukumura Y
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1985-8. PubMed ID: 8978808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of bleomycin, adriamycin and mitomycin-C in the treatment of recurrent cervical cancer.
    Meanwell CA; Luesley DM; Blackledge G; Mould JJ; Chan KK; Perren TJ; Lawton FG
    Br J Obstet Gynaecol; 1985 Jul; 92(7):756-61. PubMed ID: 2410013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group.
    Dimopoulos MA; Papadimitriou CA; Sarris K; Aravantinos G; Kalofonos C; Gika D; Gourgoulis GM; Efstathiou E; Skarlos D; Bafaloukos D
    Gynecol Oncol; 2002 Jun; 85(3):476-82. PubMed ID: 12051877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck.
    Specht L; Larsen SK; Hansen HS
    Ann Oncol; 2000 Jul; 11(7):845-9. PubMed ID: 10997812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix.
    Vermorken JB; Mangioni C; Pecorelli S; Van Der Burg ME; Van Oosterom AT; Ten Bokkel Huinink WW; Rotmensz N; Dalesio O
    Int J Gynecol Cancer; 2000 Sep; 10(5):358-365. PubMed ID: 11240699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bleomycin and mitomycin-C (BLM-M) in recurrent squamous uterine cervical carcinoma.
    Boice CR; Freedman RS; Herson J; Wharton JT; Rutledge FN
    Cancer; 1982 Jun; 49(11):2242-5. PubMed ID: 6176311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
    Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
    Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P
    Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer.
    Murad AM; Triginelli SA; Ribalta JC
    J Clin Oncol; 1994 Jan; 12(1):55-9. PubMed ID: 7505808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck.
    Glisson BS; Murphy BA; Frenette G; Khuri FR; Forastiere AA
    J Clin Oncol; 2002 Mar; 20(6):1593-9. PubMed ID: 11896109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.